RAB20

Summary

RAB20 (RAB20, member RAS oncogene family, HGNC:18260) is a protein-coding gene on chromosome 13q34, encoding Ras-related protein Rab-20 (Q9NX57). The small GTPases Rab are key regulators of intracellular membrane trafficking, from the formation of transport vesicles to their fusion with membranes.

Predicted to enable GTPase activity. Involved in phagosome acidification and phagosome-lysosome fusion. Located in Golgi apparatus and phagocytic vesicle.

Source: NCBI Gene 55647 — RefSeq curated summary.

At a glance

• GWAS associations: 2
• Clinical variants (ClinVar): 42 total
• MANE Select transcript: NM_017817

Identifiers

Gene identifiers

Field	Value
HGNC ID	HGNC:18260
Approved symbol	RAB20
Name	RAB20, member RAS oncogene family
Location	13q34
Locus type	gene with protein product
Status	Approved
Aliases	FLJ20429
Ensembl gene	ENSG00000139832
Ensembl biotype	protein_coding
Entrez	55647

Gene structure

Transcript identifiers

Ensembl transcripts: 2 — 2 protein_coding

ENST00000267328, ENST00000907762

RefSeq mRNA: 1 — MANE Select: NM_017817 NM_017817

CCDS: CCDS9512

Canonical transcript exons

ENST00000267328 — 2 exons

Exon	Start	End
ENSE00000940346	110561348	110561722
ENSE00000940347	110523066	110524197

Expression profiles

Bgee: expression breadth ubiquitous, 232 present calls, max score 98.64.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 12.4905 / max 271.5945, expressed in 1325 samples.

FANTOM5 promoters (1 alternative TSS)

Promoter ID	TPM avg	Samples expressed
138255	12.4905	1325

Top tissues by expression

275 total, by Bgee expression score (0-100, higher = more expressed):

Tissue	Anatomy ID	Expression score	Quality
secondary oocyte	CL:0000655	98.64	gold quality
oocyte	CL:0000023	96.16	gold quality
pancreatic ductal cell	CL:0002079	95.83	gold quality
mucosa of transverse colon	UBERON:0004991	92.12	gold quality
right adrenal gland cortex	UBERON:0035827	91.65	gold quality
left adrenal gland cortex	UBERON:0035825	91.38	gold quality
left adrenal gland	UBERON:0001234	91.05	gold quality
right adrenal gland	UBERON:0001233	90.80	gold quality
spleen	UBERON:0002106	90.80	gold quality
nephron tubule	UBERON:0001231	90.38	gold quality
adrenal tissue	UBERON:0018303	90.37	gold quality
adrenal gland	UBERON:0002369	90.12	gold quality
adrenal cortex	UBERON:0001235	90.00	gold quality
popliteal artery	UBERON:0002250	89.75	gold quality
tibial artery	UBERON:0007610	89.75	gold quality
monocyte	CL:0000576	89.56	gold quality
mononuclear cell	CL:0000842	89.56	gold quality
ileal mucosa	UBERON:0000331	89.55	gold quality
upper lobe of left lung	UBERON:0008952	89.54	gold quality
body of stomach	UBERON:0001161	89.49	gold quality
upper lobe of lung	UBERON:0008948	89.43	gold quality
lower lobe of lung	UBERON:0008949	89.41	silver quality
right lung	UBERON:0002167	89.24	gold quality
leukocyte	CL:0000738	88.92	gold quality
right lobe of liver	UBERON:0001114	88.84	gold quality
left coronary artery	UBERON:0001626	88.69	gold quality
metanephric glomerulus	UBERON:0004736	88.01	gold quality
aorta	UBERON:0000947	87.91	gold quality
omental fat pad	UBERON:0010414	87.73	gold quality
peritoneum	UBERON:0002358	87.61	gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 1.

Experiment	Marker?	Max mean expression
E-ANND-3	no	0.00

Regulation

Is transcription factor: no

Upstream regulators (CollecTRI, top): SP1

miRNA regulators (miRDB)

25 targeting RAB20, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNA	Max score	Avg score	miRNA target_count
HSA-MIR-3646	100.00	73.56	5283
HSA-MIR-568	99.98	69.86	2084
HSA-MIR-128-3P	99.95	71.17	2484
HSA-MIR-216A-3P	99.95	71.19	2505
HSA-MIR-7153-5P	99.94	68.89	1006
HSA-MIR-3681-3P	99.88	70.46	2254
HSA-MIR-1299	99.77	71.24	2389
HSA-MIR-4422	99.72	72.07	2908
HSA-MIR-3158-5P	99.65	67.51	1763
HSA-MIR-875-3P	99.63	69.47	2548
HSA-MIR-302B-5P	99.50	69.49	1857
HSA-MIR-302D-5P	99.50	69.34	1863
HSA-MIR-520E-5P	99.27	68.90	1513
HSA-MIR-6071	99.16	67.77	1780
HSA-MIR-5100	99.11	67.52	1098
HSA-MIR-877-3P	99.09	68.10	1637
HSA-MIR-4751	98.80	64.95	525
HSA-MIR-502-5P	98.77	66.51	906
HSA-MIR-6881-3P	98.04	68.24	1777
HSA-MIR-4257	97.86	68.05	1190
HSA-MIR-6772-3P	97.04	65.89	784
HSA-MIR-4448	97.04	66.22	752
HSA-MIR-6750-3P	96.79	67.50	740
HSA-MIR-624-5P	96.00	68.88	728
HSA-MIR-103B	95.51	66.85	441

Literature-anchored findings (GeneRIF, showing 6)

• Regulates connexin 43 intracellular transport. (PMID:18649179)
• TdIF1 associates with the RAB20 promoter, and RAB20 gene transcription is reduced in TdIF1-knocked-down cells, suggesting that TdIF1 stimulates RAB20 gene transcription. (PMID:23874396)
• Rab20 is specifically and significantly upregulated in the sputum of human patients with active tuberculosis. (PMID:28494243)
• Regulation of Small GTPase Rab20 by Ikaros in B-Cell Acute Lymphoblastic Leukemia. (PMID:32138279)
• Low oxygen saturation during sleep reduces CD1D and RAB20 expressions that are reversed by CPAP therapy. (PMID:32512511)
• TPI1-reduced extracellular vesicles mediated by Rab20 downregulation promotes aerobic glycolysis to drive hepatocarcinogenesis. (PMID:34401050)

Cross-species orthologs

4 orthologs

Organism	Symbol	Gene ID
danio_rerio	rab20	ENSDARG00000005049
mus_musculus	Rab20	ENSMUSG00000031504
rattus_norvegicus	Rab20	ENSRNOG00000023991
caenorhabditis_elegans		WBGENE00016874

Paralogs (68): RAB27B (ENSG00000041353), RAB27A (ENSG00000069974), RAB7A (ENSG00000075785), RABL2B (ENSG00000079974), RAB21 (ENSG00000080371), RAB10 (ENSG00000084733), RAB18 (ENSG00000099246), RAB36 (ENSG00000100228), IFT27 (ENSG00000100360), RAB40AL (ENSG00000102128), RAB11A (ENSG00000103769), RAB2A (ENSG00000104388), RAB3D (ENSG00000105514), RAB3A (ENSG00000105649), RAB5C (ENSG00000108774), RAB34 (ENSG00000109113), RAB5B (ENSG00000111540), RAB35 (ENSG00000111737), RAB23 (ENSG00000112210), DNAJC27 (ENSG00000115137), RAB29 (ENSG00000117280), RAB32 (ENSG00000118508), RAB14 (ENSG00000119396), RAB9B (ENSG00000123570), RAB9A (ENSG00000123595), RAB38 (ENSG00000123892), RAB22A (ENSG00000124209), RAB17 (ENSG00000124839), RAB2B (ENSG00000129472), RAB25 (ENSG00000132698), RAB33A (ENSG00000134594), RAB30 (ENSG00000137502), RAB1A (ENSG00000138069), RAB15 (ENSG00000139998), RAB40B (ENSG00000141542), RAB13 (ENSG00000143545), RABL2A (ENSG00000144134), RAB5A (ENSG00000144566), RAB19 (ENSG00000146955), RAB41 (ENSG00000147127)

Protein

Protein identifiers

Ras-related protein Rab-20 — Q9NX57 (reviewed: Q9NX57)

All UniProt accessions (1): Q9NX57

UniProt curated annotations — full annotation on UniProt →

Function. The small GTPases Rab are key regulators of intracellular membrane trafficking, from the formation of transport vesicles to their fusion with membranes. Rabs cycle between an inactive GDP-bound form and an active GTP-bound form that is able to recruit to membranes different sets of downstream effectors directly responsible for vesicle formation, movement, tethering and fusion. RAB20 plays a role in apical endocytosis/recycling. Plays a role in the maturation and acidification of phagosomes that engulf pathogens, such as S.aureus and M.tuberculosis. Plays a role in the fusion of phagosomes with lysosomes.

Subcellular location. Golgi apparatus. Cytoplasmic vesicle. Phagosome. Phagosome membrane.

Tissue specificity. Low or absent expression in normal pancreas and stronger expression in 15 of 18 exocrine pancreatic adenocarcinomas (at protein level).

Activity regulation. Regulated by guanine nucleotide exchange factors (GEFs) which promote the exchange of bound GDP for free GTP. Regulated by GTPase activating proteins (GAPs) which increase the GTP hydrolysis activity. Inhibited by GDP dissociation inhibitors (GDIs).

Domain organisation. Switch 1, switch 2 and the interswitch regions are characteristic of Rab GTPases and mediate the interactions with Rab downstream effectors. The switch regions undergo conformational changes upon nucleotide binding which drive interaction with specific sets of effector proteins, with most effectors only binding to GTP-bound Rab.

Similarity. Belongs to the small GTPase superfamily. Rab family.

RefSeq proteins (1): NP_060287* (*=MANE)

Domains & families (InterPro)

ID	Name	Type
IPR001806	Small_GTPase	Family
IPR005225	Small_GTP-bd	Domain
IPR027417	P-loop_NTPase	Homologous_superfamily
IPR041836	Rab20	Family

Pfam: PF00071

Catalyzed reactions (Rhea), 1 shown:

• GTP + H2O = GDP + phosphate + H(+) (RHEA:19669)

UniProt features (25 total): binding site 14, region of interest 2, lipid moiety-binding region 2, short sequence motif 2, compositionally biased region 2, chain 1, sequence variant 1, sequence conflict 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

Model	pLDDT	Fraction very-high
AF-Q9NX57-F1	87.02	0.72

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Ligand- & substrate-binding residues (14): 19; 32; 36; 36; 55; 58; 113; 114; 116; 184; 185; 17 …

Post-translational modifications (2): 232, 233

Function

Pathways and Gene Ontology

Reactome pathways

1 pathways

ID	Pathway
R-HSA-8873719	RAB geranylgeranylation

MSigDB gene sets: 284 (showing top): GSE45365_NK_CELL_VS_CD11B_DC_DN, GOBP_VACUOLE_ORGANIZATION, GOBP_INTRACELLULAR_PROTEIN_TRANSPORT, GOBP_RESPONSE_TO_PEPTIDE, GOBP_VESICLE_ORGANIZATION, GOBP_MEMBRANE_FUSION, GOBP_VESICLE_MEDIATED_TRANSPORT, WIELAND_UP_BY_HBV_INFECTION, GOBP_PHAGOLYSOSOME_ASSEMBLY, GOBP_DEFENSE_RESPONSE_TO_OTHER_ORGANISM, FOSTER_TOLERANT_MACROPHAGE_DN, GOBP_PHAGOSOME_MATURATION, ROZANOV_MMP14_TARGETS_UP, GOBP_ORGANELLE_MEMBRANE_FUSION, chr13q34

GO Biological Process (6): intracellular protein transport (GO:0006886), endocytosis (GO:0006897), cellular response to type II interferon (GO:0071346), phagosome acidification (GO:0090383), phagosome-lysosome fusion (GO:0090385), protein transport (GO:0015031)

GO Molecular Function (6): GTPase activity (GO:0003924), G protein activity (GO:0003925), GTP binding (GO:0005525), metal ion binding (GO:0046872), nucleotide binding (GO:0000166), hydrolase activity (GO:0016787)

GO Cellular Component (9): early endosome (GO:0005769), Golgi apparatus (GO:0005794), plasma membrane (GO:0005886), endomembrane system (GO:0012505), endocytic vesicle (GO:0030139), phagocytic vesicle membrane (GO:0030670), phagocytic vesicle (GO:0045335), membrane (GO:0016020), cytoplasmic vesicle (GO:0031410)

Reactome top-level categories

Rollup of top-1 pathways:

Category	Pathways
Post-translational protein modification	1

GO top-level categories

Rollup of top GO terms by namespace:

Category	Terms
intracellular protein localization	2
cytoplasm	2
cellular anatomical structure	2
protein transport	1
intracellular transport	1
vesicle budding from membrane	1
membrane invagination	1
vesicle-mediated transport	1
import into cell	1
response to type II interferon	1
cellular response to cytokine stimulus	1
intracellular pH reduction	1
phagosome maturation	1
phagolysosome assembly	1
vesicle fusion	1
transport	1
establishment of protein localization	1
ribonucleoside triphosphate phosphatase activity	1
GTPase activity	1
molecular function regulator activity	1
guanyl ribonucleotide binding	1
purine ribonucleoside triphosphate binding	1
cation binding	1
nucleoside phosphate binding	1
heterocyclic compound binding	1
catalytic activity	1
endosome	1
endomembrane system	1
intracellular membrane-bounded organelle	1
membrane	1
cell periphery	1
vacuole	1
plasma membrane	1
cytoplasmic vesicle	1
endocytic vesicle membrane	1
phagocytic vesicle	1
endocytic vesicle	1
intracellular vesicle	1

Protein interactions and networks

STRING

960 interactions, top by confidence (×1000):

Protein A	Protein B	Partner UniProt	Score
RAB20	RABGEF1	Q9UJ41	628
RAB20	RAB5A	P20339	462
RAB20	RIMKLA	Q8IXN7	437
RAB20	RAB10	P61026	418
RAB20	DNTTIP1	Q9H147	394
RAB20	NAXD	Q8IW45	392
RAB20	TMEM101	Q96IK0	372
RAB20	GATAD1	Q8WUU5	355
RAB20	CEBPZOS	A8MTT3	353
RAB20	PEX12	O00623	350
RAB20	SLCO5A1	Q9H2Y9	349
RAB20	WNT11	O96014	349
RAB20	PRR32	B1ATL7	316
RAB20	OSBPL1A	Q9BXW6	306
RAB20	TMEM223	A0PJW6	305

IntAct

14 interactions, top by confidence:

A	B	Type	Score
UNC119	UNC119B	psi-mi:“MI:0914”(association)	0.640
RAB20	CHM	psi-mi:“MI:0914”(association)	0.530
	RAB20	psi-mi:“MI:0883”(gtpase reaction)	0.440
	virA	psi-mi:“MI:0883”(gtpase reaction)	0.440
	HLA-C	psi-mi:“MI:0914”(association)	0.350
Npc1	ESYT2	psi-mi:“MI:0914”(association)	0.350
RAB20	BCL10	psi-mi:“MI:0914”(association)	0.350
MFSD11	PLD2	psi-mi:“MI:0914”(association)	0.350
SLC27A5	MEIOC	psi-mi:“MI:0914”(association)	0.350
SLC39A11	ESYT2	psi-mi:“MI:0914”(association)	0.350
SLC39A12	ESYT2	psi-mi:“MI:0914”(association)	0.350
SV2B	C15orf61	psi-mi:“MI:0914”(association)	0.350

BioGRID (27): RAB20 (Affinity Capture-RNA), RAB20 (Affinity Capture-MS), RAB20 (Affinity Capture-RNA), ANKRD13D (Affinity Capture-MS), TFCP2 (Affinity Capture-MS), RAP1GDS1 (Affinity Capture-MS), CHM (Affinity Capture-MS), CHML (Affinity Capture-MS), PGGT1B (Affinity Capture-MS), ALKBH1 (Affinity Capture-MS), MINA (Affinity Capture-MS), UBP1 (Affinity Capture-MS), SPATA20 (Affinity Capture-MS), CTU2 (Affinity Capture-MS), RABGGTA (Affinity Capture-MS)

ESM2 similar proteins: A1DZY4, A6QP66, O35626, O35929, O88910, O88954, P0C0E4, P35295, P51157, P51158, P53667, P53668, P53669, P55040, P55041, P55043, P63032, P63033, Q06AU5, Q12829, Q13368, Q13637, Q3SWY9, Q5E9J3, Q5FVY2, Q5R541, Q5RFI2, Q6DGN0, Q6IMA3, Q6IMA7, Q6IMB1, Q6P0U3, Q6T310, Q8AVS6, Q8IYK8, Q8QFP8, Q8VEL9, Q8VHP8, Q8VHQ4, Q8WXH6

Diamond homologs: A4FV54, C4YL11, C8VQY7, M0RC99, O04157, O23657, O24461, O42819, O49841, O76173, O76742, O94655, P07560, P0CY30, P0CY31, P18066, P20339, P22127, P22128, P24409, P29687, P31582, P31583, P34142, P35278, P35280, P35282, P35285, P35292, P35295, P36411, P36586, P36864, P41924, P41925, P51147, P51148, P51153, P55258, P55745

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

42 variants total. Per-class counts are floors (≥ shown; pagination cap):

Classification	Count (floor)
Pathogenic	0
Likely pathogenic	0
Uncertain significance	40
Likely benign	1
Benign	0

Top pathogenic / likely-pathogenic (0)

SpliceAI

679 predictions. Top by Δscore:

Variant	Effect	Δscore
13:110524193:CCGCC:C	acceptor_gain	1.0000
13:110524194:CGCC:C	acceptor_gain	1.0000
13:110524194:CGCCC:C	acceptor_gain	1.0000
13:110524195:GCC:G	acceptor_gain	1.0000
13:110524196:CC:C	acceptor_gain	1.0000
13:110524196:CCC:C	acceptor_gain	1.0000
13:110524197:CC:C	acceptor_gain	1.0000
13:110524198:C:CA	acceptor_loss	1.0000
13:110524198:C:CC	acceptor_gain	1.0000
13:110524198:C:T	acceptor_gain	1.0000
13:110524199:T:C	acceptor_loss	1.0000
13:110524201:G:GC	acceptor_gain	1.0000
13:110561342:CCTCA:C	donor_loss	1.0000
13:110561343:CTCA:C	donor_loss	1.0000
13:110561344:TCA:T	donor_loss	1.0000
13:110561345:CA:C	donor_loss	1.0000
13:110561346:A:AT	donor_loss	1.0000
13:110561347:C:CT	donor_loss	1.0000
13:110524201:G:C	acceptor_gain	0.9900
13:110540205:G:C	donor_gain	0.9900
13:110561347:CCTG:C	donor_gain	0.9900
13:110524195:GCCCT:G	acceptor_gain	0.9700
13:110542754:C:CC	acceptor_gain	0.9700
13:110561346:A:AC	donor_gain	0.9700
13:110561347:C:CC	donor_gain	0.9700
13:110524196:CCCTG:C	acceptor_gain	0.9600
13:110524198:CT:C	acceptor_gain	0.9600
13:110524197:CCT:C	acceptor_gain	0.9500
13:110524199:T:G	acceptor_gain	0.9400
13:110534579:TTG:T	donor_gain	0.9400

AlphaMissense

1542 scored. Top likely-pathogenic:

Variant	Protein change	am_pathogenicity
13:110524029:T:A	K114I	0.999
13:110524184:G:C	F62L	0.999
13:110524184:G:T	F62L	0.999
13:110524186:A:G	F62L	0.999
13:110561356:T:A	D55V	0.999
13:110561356:T:G	D55A	0.999
13:110524028:T:A	K114N	0.998
13:110524028:T:G	K114N	0.998
13:110561357:C:G	D55H	0.998
13:110561360:A:G	W54R	0.998
13:110561360:A:T	W54R	0.998
13:110523821:G:C	S183R	0.997
13:110523821:G:T	S183R	0.997
13:110523823:T:G	S183R	0.997
13:110561355:G:C	D55E	0.997
13:110561355:G:T	D55E	0.997
13:110561356:T:C	D55G	0.997
13:110561449:C:G	R24P	0.997
13:110561430:G:C	F30L	0.996
13:110561430:G:T	F30L	0.996
13:110561432:A:G	F30L	0.996
13:110561470:C:T	G17E	0.996
13:110561485:C:T	G12E	0.996
13:110561486:C:G	G12R	0.996
13:110561486:C:T	G12R	0.996
13:110523819:G:T	A184D	0.995
13:110524030:T:C	K114E	0.995
13:110524109:G:C	S87R	0.995
13:110524109:G:T	S87R	0.995
13:110524111:T:G	S87R	0.995

dbSNP variants (sampled 300 via entrez): RS1000102567 (13:110549434 G>A), RS1000259928 (13:110546102 A>C), RS1000362361 (13:110538691 G>C), RS1000392683 (13:110556167 A>C,T), RS1000484134 (13:110534084 G>A,T), RS1000606291 (13:110541887 A>T), RS1000737784 (13:110545722 G>A), RS1000765228 (13:110540062 T>C), RS1000775564 (13:110531015 T>C,G), RS1000818333 (13:110538975 G>T), RS1000846294 (13:110523848 G>A), RS1000857306 (13:110557067 G>A,C), RS1000876000 (13:110523508 C>A,T), RS1000916896 (13:110552998 G>A), RS1000951299 (13:110536169 G>A,C)

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

2 associations (top):

Study	Trait	p-value
GCST004253_3	Accelerated cognitive decline after conversion of mild cognitive impairment to Alzheimer’s disease (Alzhiemer’s diagnosis trajectory interaction)	2.000000e-06
GCST010653_23	Thyroid stimulating hormone levels	9.000000e-09

EFO canonical traits (1, from GWAS)

EFO ID	Trait name
EFO:0007710	cognitive decline measurement

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

62 total (human), top 30 by PubMed support.

Chemical	Actions (top 5)	PubMed papers
Valproic Acid	affects cotreatment, increases expression, affects expression, increases methylation	9
trichostatin A	affects cotreatment, increases expression	3
Acetaminophen	decreases expression, affects response to substance	3
Benzo(a)pyrene	decreases expression, increases methylation, affects methylation	3
mercuric bromide	increases expression, affects cotreatment	2
entinostat	increases expression, affects cotreatment	2
Vorinostat	affects cotreatment, increases expression	2
Panobinostat	affects cotreatment, increases expression	2
Phenylmercuric Acetate	increases expression, affects cotreatment	2
p-Chloromercuribenzoic Acid	increases expression, affects cotreatment	2
aristolochic acid I	decreases expression	1
methylmercuric chloride	increases expression	1
triphenyl phosphate	affects expression	1
bisphenol A	affects cotreatment, increases methylation	1
glycidyl methacrylate	decreases expression	1
sulforaphane	decreases expression	1
zinc chloride	decreases reaction, increases expression	1
sodium arsenite	decreases expression	1
cobaltous chloride	decreases reaction, increases expression	1
ferrous chloride	decreases expression	1
aflatoxin B2	decreases methylation	1
1-nitropyrene	decreases expression	1
di-n-butylphosphoric acid	affects expression	1
Am 580	increases expression	1
CGP 52608	affects binding, increases reaction	1
4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	increases expression, affects cotreatment	1
abrine	decreases expression	1
dorsomorphin	increases expression, affects cotreatment	1
Rosiglitazone	increases expression	1
Sunitinib	increases expression	1

Cellosaurus cell lines

4 cell lines: 4 cancer cell line

First 10 cell lines (id-ordered, not curated):

Cellosaurus	Name	Category	Sex
CVCL_B2D0	Abcam HeLa RAB20 KO	Cancer cell line	Female
CVCL_TI01	HAP1 RAB20 (-) 1	Cancer cell line	Male
CVCL_TI02	HAP1 RAB20 (-) 2	Cancer cell line	Male
CVCL_TI03	HAP1 RAB20 (-) 3	Cancer cell line	Male

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.